Eosinophilic Esophagitis - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Eosinophilic Esophagitis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Eosinophilic Esophagitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Eosinophilic Esophagitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Eosinophilic Esophagitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Eosinophilic Esophagitis - Overview
  5. Pipeline Products for Eosinophilic Esophagitis - Comparative Analysis
  6. Eosinophilic Esophagitis - Therapeutics under Development by Companies
  7. Eosinophilic Esophagitis - Therapeutics under Investigation by Universities/Institutes
  8. Eosinophilic Esophagitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Eosinophilic Esophagitis - Products under Development by Companies
  13. Eosinophilic Esophagitis - Products under Investigation by Universities/Institutes
  14. Eosinophilic Esophagitis - Companies Involved in Therapeutics Development
  • Celgene Corporation
  • DBV Technologies S.A.
  • Dr. Falk Pharma GmbH
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.
  • Shire Plc

For more information visit http://www.researchandmarkets.com/research/659shb/eosinophilic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Gastrointestinal Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Gastrointestinal Drugs